Unlike previous generations of weight loss injections, which typically targeted only one hormone receptor, tirzepatides dual-action formula allows it to communicate more effectively with the brain and digestive system
Stimulation of collagen synthesis by the tripeptide copper complex GHK-Cu Hostynek JJ, et al
At 48 weeks, 26% of participants on 12 mg had lost 30% or more of body weight
Side Effects, Safety, and Tolerability Profiles Both tirzepatide and Wegovy cause similar gastrointestinal side effects during the early weeks: nausea, constipation, and reduced appetite
Clinical studies showed patients using CONTRAVE with diet and exercise achieved significantly greater weight loss than diet and exercise alone, and results were sustained over one year